The RATIO group is supported by a research grant from INSERM (Réseau de Recherche en santé des Populations 2003 and 2006) and by an unrestricted grant from Abbott, Schering Plough and Wyeth. The authors thank also the French Society of, SFR) subgroup: the CRI (Club Rheumatism and Inflammation) and the French Society of Infectious Diseases (SPLIF) ,
Le Kremlin-Bicêtre 94270, France. 3 Infectious Diseases - Internal Medicine Department, Cochin Hospital, AP-HP, 27 rue de faubourg Saint-Jacques ,
Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis, Arthritis & Rheumatism, vol.6, issue.9, pp.1552-1563, 1998. ,
DOI : 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W
Treatment of Ankylosing Spondylitis by Inhibition of Tumor Necrosis Factor ??, New England Journal of Medicine, vol.346, issue.18, pp.1349-1356, 2002. ,
DOI : 10.1056/NEJMoa012664
Cytokine blockers in psoriatic arthritis, Ann Rheum Dis, vol.60, issue.3, pp.37-40, 2001. ,
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial, Arthritis & Rheumatism, vol.36, issue.11, pp.126-135, 2008. ,
DOI : 10.1002/art.21405
Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo-controlled, 52-week trial, Arthritis & Rheumatism, vol.46, issue.5, pp.1400-1411, 2004. ,
DOI : 10.1002/art.20217
Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis, Arthritis & Rheumatism, vol.54, issue.12, pp.3928-3939, 2007. ,
DOI : 10.1002/art.23141
Joint surgery in the Utrecht Rheumatoid Arthritis Cohort: the effect of treatment strategy, Annals of the Rheumatic Diseases, vol.65, issue.11, pp.1506-1511, 2006. ,
DOI : 10.1136/ard.2005.049957
Declining use of orthopedic surgery in patients with rheumatoid arthritis? Results of a long-term, population-based assessment, Arthritis & Rheumatism, vol.49, issue.2, pp.216-220, 2003. ,
DOI : 10.1002/art.10998
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor ?????Neutralizing Agent, New England Journal of Medicine, vol.345, issue.15, pp.1098-1104, 2001. ,
DOI : 10.1056/NEJMoa011110
Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective french research axed on tolerance of biotherapies registry, Arthritis & Rheumatism, vol.18, issue.7, pp.1884-1894, 2009. ,
DOI : 10.1002/art.24632
URL : https://hal.archives-ouvertes.fr/inserm-00400633
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies, JAMA, vol.295, issue.19, pp.2275-2285, 2006. ,
DOI : 10.1001/jama.295.19.2275
The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events, Annals of the Rheumatic Diseases, vol.68, issue.7, pp.1136-1145, 2009. ,
DOI : 10.1136/ard.2008.091025
Infections during tumour necrosis factor-?? blocker therapy for rheumatic diseases in daily practice: a systematic retrospective study of 709 patients, Rheumatology, vol.46, issue.2, pp.327-334, 2007. ,
DOI : 10.1093/rheumatology/kel236
Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor ?? antagonists, Arthritis & Rheumatism, vol.149, issue.4, pp.1125-1133, 2007. ,
DOI : 10.1002/art.22504
Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti???tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register, Arthritis & Rheumatism, vol.50, issue.8, pp.2368-2376, 2006. ,
DOI : 10.1002/art.21978
Anti???tumor necrosis factor ?? therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis, Arthritis & Rheumatism, vol.58, issue.6, pp.1754-1764, 2007. ,
DOI : 10.1002/art.22600
Infection After Shoulder Arthroplasty, Clinical Orthopaedics and Related Research, vol.382, pp.206-216, 2001. ,
DOI : 10.1097/00003086-200101000-00028
Total Hip and Total Knee Replacement, New England Journal of Medicine, vol.323, issue.12, pp.801-807, 1990. ,
DOI : 10.1056/NEJM199009203231206
Infection du site op??ratoire apr??s arthroplastie totale de genou, Revue de Chirurgie Orthop??dique et R??paratrice de l'Appareil Moteur, vol.93, issue.6, pp.582-587, 2007. ,
DOI : 10.1016/S0035-1040(07)92680-X
Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis, Arthritis & Rheumatism, vol.82, issue.12, pp.1713-1720, 2008. ,
DOI : 10.1002/art.24060
Infection After Knee Arthroplasty, The Journal of Arthroplasty, vol.23, issue.3, pp.355-359, 2008. ,
DOI : 10.1016/j.arth.2007.05.052
Elective orthopedic surgery and perioperative DMARD management: many questions, fewer answers, and some opinions, J Rheumatol, vol.34, pp.653-655, 2007. ,
Tumour necrosis factor ?? antagonists and early postoperative complications in patients with inflammatory joint disease undergoing elective orthopaedic surgery, Annals of the Rheumatic Diseases, vol.64, issue.4, pp.650-651, 2005. ,
DOI : 10.1136/ard.2004.028365
Infectious and Healing Complications after Elective Orthopaedic Foot and Ankle Surgery during Tumor Necrosis Factor-Alpha Inhibition Therapy, Foot & Ankle International, vol.18, issue.5, pp.331-335, 2004. ,
DOI : 10.1177/107110070402500510
Profiling Remicade Onset with MTX in a Prospective Trial: Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis, J Rheumatol, vol.29, pp.667-677, 2002. ,
Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis, Arthritis & Rheumatism, vol.47, issue.2, pp.333-337, 2006. ,
DOI : 10.1002/art.21841
Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers, Clin Exp Rheumatol, vol.25, pp.430-436, 2007. ,
Risk Factors for Prosthetic Joint Infection: Case???Control Study, Clinical Infectious Diseases, vol.27, issue.5, pp.1247-1254, 1998. ,
DOI : 10.1086/514991
The RATIO observatory: French registry of??opportunistic infections, severe bacterial infections, and??lymphomas complicating anti-TnF?? therapy, Joint Bone Spine, vol.72, issue.6, pp.456-460, 2005. ,
DOI : 10.1016/j.jbspin.2005.10.004
ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials American College of Rheumatology European League of Associations for Rheumatology, J Rheumatol, vol.26, pp.705-711, 1999. ,
CDC definitions for nosocomial infections, 1988, CDC definitions for nosocomial infections, pp.128-140, 1988. ,
DOI : 10.1016/0196-6553(88)90053-3
Infection after Total Hip Arthroplasty. A Study of the Treatment of One Hundred and Six Infections*, The Journal of Bone & Joint Surgery, vol.78, issue.4, pp.512-523, 1996. ,
DOI : 10.2106/00004623-199604000-00005
Infection After Total Knee Arthroplasty. A Retrospective Study of the Treatment of Eighty-One Infections*, The Journal of Bone & Joint Surgery, vol.81, issue.10, pp.1434-1445, 1999. ,
DOI : 10.2106/00004623-199910000-00008
Outcome of Prosthetic Joint Infection in Patients with Rheumatoid Arthritis: The Impact of Medical and Surgical Therapy in 200 Episodes, Clinical Infectious Diseases, vol.42, issue.2, pp.216-223, 2006. ,
DOI : 10.1086/498507
Tumor Necrosis Factor and Wound Healing, Annals of Surgery, vol.211, issue.2, pp.124-129, 1990. ,
DOI : 10.1097/00000658-199002000-00002
Predictors of infection in rheumatoid arthritis, Arthritis & Rheumatism, vol.140, issue.9, pp.2294-2300, 2002. ,
DOI : 10.1002/art.10529
Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis? Rheumatology, pp.1157-1160, 2007. ,
A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis, Hepatology, vol.18, issue.Suppl 2, pp.1390-1397, 2004. ,
DOI : 10.1002/hep.20206
Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study, J Rheumatol, vol.34, pp.689-695, 2007. ,
Recommendations of??the??French Society for??Rheumatology. TNF?? antagonist therapy in??rheumatoid arthritis, Joint Bone Spine, vol.73, issue.4, pp.433-441, 2006. ,
DOI : 10.1016/j.jbspin.2006.04.001
URL : https://hal.archives-ouvertes.fr/hal-00465298
Medicijnen: het toepassen van TNF blokkade in de behandeling reumatoïde artritis, 2003. ,
Recurrence of infection after revision of infected hip arthroplasty, J Bone Joint Surg Br, vol.77, pp.307-309, 1995. ,
Update on the British Society for Rheumatology guidelines for prescribing TNF?? blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001), Rheumatology, vol.44, issue.2, pp.157-163, 2001. ,
DOI : 10.1093/rheumatology/keh464
Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery, Annals of the Rheumatic Diseases, vol.60, issue.3, pp.214-217, 2001. ,
DOI : 10.1136/ard.60.3.214
Postoperative joint infections in rheumatoid arthritis patients on methotrexate therapy, Orthopedics, vol.19, pp.207-210, 1996. ,
Should methotrexate be discontinued before elective orthopedic surgery in patients with rheumatoid arthritis?, J Rheumatol, vol.18, pp.984-988, 1991. ,
Microbiology of the infected knee arthroplasty: Report from the Swedish Knee Arthroplasty Register on 426 surgically revised cases, Scandinavian Journal of Infectious Diseases, vol.329, issue.11-12, pp.831-840, 2009. ,
DOI : 10.1007/s11373-007-9194-y
Increasing risk of revision due to deep infection after hip arthroplasty, Acta Orthopaedica, vol.31, issue.466, pp.639-645, 2009. ,
DOI : 10.1086/520285
Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor ??-blockers: a case-control study, Arthritis Research & Therapy, vol.12, issue.4, pp.10-1186, 2010. ,
DOI : 10.1186/ar3087
URL : https://hal.archives-ouvertes.fr/inserm-00663730